Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene

被引:26
作者
Dupuis, Annie [1 ,2 ]
Keenan, Katherine [3 ]
Ooi, Chee Y. [4 ,5 ]
Dorfman, Ruslan [6 ]
Sontag, Marci K. [7 ]
Naehrlich, Lutz [8 ]
Castellani, Carlo [9 ]
Strug, Lisa J. [2 ,10 ,11 ]
Rommens, Johanna M. [10 ,11 ,12 ]
Gonska, Tanja [2 ,13 ]
机构
[1] Hosp Sick Children, Res Inst, Clin Res Serv, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Hosp Sick Children, Res Inst, Program Physiol & Expt Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[4] Univ New S Wales, Fac Med, Discipline Paediat, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[5] Sydney Childrens Hosp Randwick, Dept Gastroenterol, Sydney, NSW, Australia
[6] GeneYouIn Inc, Toronto, ON, Canada
[7] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA
[8] Univ Giessen, Dept Pediat, D-35390 Giessen, Germany
[9] Azienda Osped Univ Integrata, Cyst Fibrosis Ctr, Verona, Italy
[10] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[11] Univ Toronto, Div Biostat, Toronto, ON, Canada
[12] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[13] Univ Toronto, Dept Pediat, Toronto, ON, Canada
关键词
cystic fibrosis; cystic fibrosis transmembrane conductance regulator gene; genotype-phenotype study; meconium ileus prevalence; pancreas insufficiency prevalence; COMMON MUTATION; SEVERE DISEASE; PHENOTYPE; RISK; POPULATION; GENOTYPE; METHAMPHETAMINE; IDENTIFICATION; CONSEQUENCES; ASSOCIATION;
D O I
10.1038/gim.2015.79
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Rationale: Meconium ileus (MI) is a perinatal complication in cystic fibrosis (CF), which is only minimally influenced by environmental factors. We derived and examined MI prevalence (MIP) scores to assess CFTR phenotype-phenotype correlation for severe mutations. Method: MIP scores were established using a Canadian CF population (n = 2,492) as estimates of the proportion of patients with MI among all patients carrying the same CFTR mutation, focusing on patients with p.F508del as the second allele. Comparisons were made to the registries from the US CF Foundation (n = 43,432), Italy (Veneto/Trentino/Alto Adige regions) (n = 1,788), and Germany (n = 3,596). Results: The prevalence of MI varied among the different registries (13-21%). MI was predominantly prevalent in patients with pancreatic insufficiency carrying "severe" CFTR mutations. In this severe spectrum MIP scores further distinguished between mutation types, for example, G542X (0.31) with a high, F508del (0.22) with a moderate, and G551D (0.08) with a low MIP score. Higher MIP scores were associated with more severe clinical phenotypes, such as a lower forced expiratory volume in 1 second (P = 0.01) and body mass index z score (P = 0.04). Conclusions: MIP scores can be used to rank CFTR mutations according to their clinical severity and provide a means to expand delineation of CF phenotypes.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 42 条
  • [1] Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas
    Ahmed, N
    Corey, M
    Forstner, G
    Zielenski, J
    Tsui, LC
    Ellis, L
    Tullis, E
    Durie, P
    [J]. GUT, 2003, 52 (08) : 1159 - 1164
  • [2] Methamphetamine and other substance use during pregnancy: Preliminary estimates from the infant development, environment, and lifestyle (IDEAL) study
    Arria, Amelia M.
    Derauf, Chris
    LaGasse, Linda L.
    Grant, Penny
    Shah, Rizwan
    Smith, Lynne
    Haning, William
    Huestis, Marilyn
    Strauss, Arthur
    Della Grotta, Sheri
    Liu, Jing
    Lester, Barry
    [J]. MATERNAL AND CHILD HEALTH JOURNAL, 2006, 10 (03) : 293 - 302
  • [3] Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis
    Blackman, Scott M.
    Deering-Brose, Rebecca
    McWilliams, Rita
    Naughton, Kathleen
    Coleman, Barbara
    Lai, Teresa
    Algire, Marilyn
    Beck, Suzanne
    Hoover-Fong, Julie
    Hamosh, Ada
    Fallin, M. Daniele
    West, Kristen
    Arking, Dan E.
    Chakravarti, Aravinda
    Cutler, David J.
    Cutting, Garry R.
    [J]. GASTROENTEROLOGY, 2006, 131 (04) : 1030 - 1039
  • [4] G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects
    Bompadre, Silvia G.
    Sohma, Yoshiro
    Li, Min
    Hwang, Tzyh-Chang
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 2007, 129 (04) : 285 - 298
  • [5] Genetic modifiers of nutritional status in cystic fibrosis
    Bradley, Gia M.
    Blackman, Scott M.
    Watson, Christopher P.
    Doshi, Vishal K.
    Cutting, Garry R.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 96 (06) : 1299 - 1308
  • [6] APPLICATION OF HIERARCHICAL LINEAR-MODELS TO ASSESSING CHANGE
    BRYK, AS
    RAUDENBUSH, SW
    [J]. PSYCHOLOGICAL BULLETIN, 1987, 101 (01) : 147 - 158
  • [7] A review of pathophysiology and management of fetuses and neonates with meconium ileus for the pediatric surgeon
    Carlyle, Brent E.
    Borowitz, Drucy S.
    Glick, Philip L.
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2012, 47 (04) : 772 - 781
  • [8] Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?
    Dorfman, R.
    Nalpathamkalam, T.
    Taylor, C.
    Gonska, T.
    Keenan, K.
    Yuan, X. W.
    Corey, M.
    Tsui, L-C
    Zielenski, J.
    Durie, P.
    [J]. CLINICAL GENETICS, 2010, 77 (05) : 464 - 473
  • [9] Meconium Ileus in Patients With Cystic Fibrosis Is Not a Risk Factor for Clinical Deterioration and Survival: The Israeli Multicenter Study
    Efrati, Ori
    Nir, Judith
    Fraser, Drora
    Cohen-Cymberknoh, Malena
    Shoseyov, David
    Vilozni, Daphna
    Modan-Moses, Dalit
    Levy, Ran
    Szeinberg, Amir
    Kerem, Eitan
    Rivlin, Joseph
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 (02) : 173 - 178
  • [10] Feingold J, 1999, ANN GENET-PARIS, V42, P147